Cordani Ramona, Stagnaro Michela, Pisciotta Livia, Tiziano Francesco Danilo, Calevo Maria Grazia, Nobili Lino, De Grandis Elisa
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
Child Neuropsychiatry Unit, Department of Clinical and Surgical Neurosciences and Rehabilitation, Istituto di Ricovero e Cura a Carattere Scientifico Giannina Gaslini, Genova, Italy.
Front Neurol. 2021 Apr 8;12:658451. doi: 10.3389/fneur.2021.658451. eCollection 2021.
Alternating hemiplegia of childhood is a rare neurological disease characterized by paroxysmal movement disorders and chronic neurological disturbances, with onset before 18 months of age. Mutations in the gene have been identified in up to 80% of patients. Thirty-nine patients [20 females, 19 males, mean age 25.32 years (7.52-49.34)] have been recruited through the Italian Biobank and Clinical Registry for Alternating Hemiplegia of Childhood. Demographic data, genotype, paroxysmal movement disorders, chronic neurological features, and response to flunarizine have been analyzed. gene mutations have been detected in 92.3% of patients. Patients have been divided into three groups-p.Asp801Asn mutation patients (26%), p.Glu815Lys cases (23%), and patients with other mutations-and statistically compared. The Italian cohort has a higher percentage of gene mutation than reported in literature (92.3%). Our data confirm a more severe phenotype in patients with p.Glu815Lys mutation, with an earlier age of onset of plegic ( = 0.02 in the correlation with other mutations) and tonic attacks. P.Glu815Lys patients most frequently present altered muscle tone, inability to walk ( = 0.01 comparing p.Glu815Lys and p.Asp801Asn mutations), epilepsy, and a more severe grade of dystonia ( < 0.05 comparing p.Glu815Lys and p.Asp801Asn mutations). They have moderate/severe intellectual disability and severe language impairment ( < 0.05). Interestingly, flunarizine seems to be more efficacious in patients with p.Glu815Lys mutation than p.Asp801Asn. In conclusion, our research suggests a genotype-phenotype correlation and provides information on this disorder's features, clinical course, and treatment.
儿童交替性偏瘫是一种罕见的神经系统疾病,其特征为阵发性运动障碍和慢性神经功能紊乱,发病年龄在18个月之前。高达80%的患者已被确定存在该基因突变。通过意大利儿童交替性偏瘫生物样本库和临床登记系统招募了39例患者[20名女性,19名男性,平均年龄25.32岁(7.52 - 49.34岁)]。分析了人口统计学数据、基因型、阵发性运动障碍、慢性神经功能特征以及对氟桂利嗪的反应。92.3%的患者检测到该基因突变。患者被分为三组——p.Asp801Asn突变患者(26%)、p.Glu815Lys病例(23%)以及其他该基因突变的患者——并进行统计学比较。意大利队列中该基因突变的比例高于文献报道(92.3%)。我们的数据证实,p.Glu815Lys突变患者的表型更为严重,偏瘫发作(与其他突变的相关性中P = 0.02)和强直性发作的发病年龄更早。p.Glu815Lys患者最常出现肌张力改变、无法行走(比较p.Glu815Lys和p.Asp801Asn突变时P = 0.01)、癫痫以及更严重程度的肌张力障碍(比较p.Glu815Lys和p.Asp801Asn突变时P < 0.05)。他们有中度/重度智力残疾和严重语言障碍(P < 0.05)。有趣的是,氟桂利嗪对p.Glu815Lys突变患者似乎比对p.Asp801Asn突变患者更有效。总之,我们的研究表明了基因型与表型的相关性,并提供了有关该疾病特征、临床病程和治疗的信息。